Cell line name |
91T |
Accession |
CVCL_A2AT |
Resource Identification Initiative |
To cite this cell line use: 91T (RRID:CVCL_A2AT) |
Comments |
From: Siegfried, Jill M.; University of Pittsburgh; Pittsburgh; USA. Miscellaneous: Age of donor from personal communication of Siegfried, Jill M. Derived from site: In situ; Lung; UBERON=UBERON_0002048. |
Sequence variations |
|
Disease |
Lung adenocarcinoma (NCIt: C3512) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Male |
Age at sampling |
51Y |
Category |
Cancer cell line |
Publications | PubMed=10545285; DOI=10.1006/pupt.1999.0210 Jill M. Siegfried, Nandigama Krishnamachary, Autumn L. Gaither Davis, Christopher T. Gubish, Jay D. Hunt, Sharon Persinger Shriver; Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancer. Pulm. Pharmacol. Ther. 12:291-302(1999) PubMed=11929836 Laura P. Stabile, Autumn L. Gaither Davis, Christopher T. Gubish, Toni M. Hopkins, James D. Luketich, Neil Christie, Sydney Finkelstein, Jill M. Siegfried; Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 62:2141-2150(2002) PubMed=18645002; DOI=10.1158/1535-7163.MCT-07-2169; PMCID=PMC2556508 Laura P. Stabile, Mary E. Rothstein, Phouthone Keohavong, Jide Jin, Jin-Ling Yin, Stephanie R. Land, Sanja Dacic, The Minh Luong, K. Jin Kim, Austin M. Dulak, Jill M. Siegfried; Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis. Mol. Cancer Ther. 7:1913-1922(2008) |
Cross-references |
Cell line databases/resources |
cancercelllines; CVCL_A2AT
|
Encyclopedic resources |
Wikidata; Q105505987
|
Entry history |
Entry creation | 12-Jan-2021 |
Last entry update | 19-Dec-2024 |
Version number | 7 |
---|